Health Tech

Find More: Biotech Pharma
- Advertisement -
Ad imageAd image
Nissha Medical Technologies Expands U.S. Micro Molding Operations Amid Rising Demand for Miniaturized Medical Devices

Japan medical manufacturing firm Nissha Co. Ltd. is building upon its worldwide healthcare technology presence through a significant United States micro molding initiative. Its division, Nissha Medical Technologies recently invested…

Eisai seeks FDA approval for LEQEMBI Subcutaneous dose

Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…

MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…

Hitachi and Partners build generative AI healthcare platform

Hitachi Systems, Ltd., Kanagawa Prefecture, MedMirai Co., Ltd., and the University of…

Eisai’s Tazemetostat Approved as Orphan Drug in Japan

Eisai Co., Ltd. announced that it has received orphan drug designation for…

Top 10 Tech-Driven Solutions Tackling Japan’s Aging Population

Japan is known for its resilience and innovation. Its cultural values also…

Celaid Therapeutics and AGC sign iPSC-HSPC research deal

Celaid Therapeutics Inc. Celaid has teamed up with AGC Inc. for a…

Fujitsu Unveils AI Agent Platform for Healthcare Efficiency

Fujitsu announced the development of a secure and efficient AI agent platform…

Omi Japan and Kyoto Health Partner on Medical DX MoU

Omi Japan Co., Ltd., the Japanese subsidiary of the Omi Group, which…

Eisai seeks FDA approval for LEQEMBI Subcutaneous dose

Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…

MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…

Hitachi and Partners build generative AI healthcare platform

Hitachi Systems, Ltd., Kanagawa Prefecture, MedMirai Co., Ltd., and the University of…

Eisai’s Tazemetostat Approved as Orphan Drug in Japan

Eisai Co., Ltd. announced that it has received orphan drug designation for…

Top 10 Tech-Driven Solutions Tackling Japan’s Aging Population

Japan is known for its resilience and innovation. Its cultural values also…

Celaid Therapeutics and AGC sign iPSC-HSPC research deal

Celaid Therapeutics Inc. Celaid has teamed up with AGC Inc. for a…

Fujitsu Unveils AI Agent Platform for Healthcare Efficiency

Fujitsu announced the development of a secure and efficient AI agent platform…

Omi Japan and Kyoto Health Partner on Medical DX MoU

Omi Japan Co., Ltd., the Japanese subsidiary of the Omi Group, which…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community